1. Home
  2. ENTX vs COE Comparison

ENTX vs COE Comparison

Compare ENTX & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • COE
  • Stock Information
  • Founded
  • ENTX 2010
  • COE 2011
  • Country
  • ENTX Israel
  • COE Singapore
  • Employees
  • ENTX N/A
  • COE N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • COE Other Consumer Services
  • Sector
  • ENTX Health Care
  • COE Real Estate
  • Exchange
  • ENTX Nasdaq
  • COE Nasdaq
  • Market Cap
  • ENTX 90.2M
  • COE 102.9M
  • IPO Year
  • ENTX 2018
  • COE 2016
  • Fundamental
  • Price
  • ENTX $2.34
  • COE $20.10
  • Analyst Decision
  • ENTX Strong Buy
  • COE
  • Analyst Count
  • ENTX 1
  • COE 0
  • Target Price
  • ENTX $10.00
  • COE N/A
  • AVG Volume (30 Days)
  • ENTX 227.4K
  • COE 25.2K
  • Earning Date
  • ENTX 03-07-2025
  • COE 12-13-2024
  • Dividend Yield
  • ENTX N/A
  • COE N/A
  • EPS Growth
  • ENTX N/A
  • COE N/A
  • EPS
  • ENTX N/A
  • COE N/A
  • Revenue
  • ENTX $99,000.00
  • COE $41,924,000.00
  • Revenue This Year
  • ENTX N/A
  • COE N/A
  • Revenue Next Year
  • ENTX N/A
  • COE N/A
  • P/E Ratio
  • ENTX N/A
  • COE N/A
  • Revenue Growth
  • ENTX 607.14
  • COE 69.79
  • 52 Week Low
  • ENTX $0.68
  • COE $6.00
  • 52 Week High
  • ENTX $3.35
  • COE $21.97
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 54.52
  • COE 65.30
  • Support Level
  • ENTX $2.19
  • COE $19.13
  • Resistance Level
  • ENTX $2.79
  • COE $21.97
  • Average True Range (ATR)
  • ENTX 0.23
  • COE 1.44
  • MACD
  • ENTX -0.03
  • COE -0.06
  • Stochastic Oscillator
  • ENTX 40.40
  • COE 67.26

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand.

Share on Social Networks: